Nucor Upgraded by UBS to Buy with $190 Target
UBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
After an IRA rollover, selecting the right index fund matters for long-term growth and risk management. Compare options and choose confidently.
26,327 articlesUBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
Investing in cosmetics often blends branding bias with numbers. This guide looks at whether e.l.f. beauty stock rhode...
Regulators opened a public comment period to redefine how crypto perpetual futures are labeled, a move that could res...
Two leading travel platforms, Booking Holdings and Airbnb, each chart different revenue paths. This article breaks do...
Walmart and Target face divergent paths in 2026, with valuation gaps, income potential, and strategy shaping whether ...
Tesla posts stronger margins amid a delivery dip, while Rivian turns profitable on software and a hopeful R2 ramp. An...
Two pharma giants compete for your portfolio's income. This guide weighs yields, safety, and long-term risks to answe...
If you’re weighing Nvidia versus Alphabet for AI chip exposure, this guide breaks down the opportunity, the risks, an...
As the EV market accelerates, investors face a key question: which stock—Rivian or Tesla—fits their risk tolerance an...
In 2026, two retail powerhouses—Chewy and Walmart—face very different growth paths. This guide dissects their models,...
When CPSS releases its earnings, it can move the stock and shape investor sentiment for months. This guide breaks dow...
Nebius stock all-time high sparked a flurry of questions. This guide breaks down the drivers, the risks, and a practi...